LPA and diabetes mellitus: Increasing Lp(a) levels were significantly associated with the risk of the composite of recurrent MI and all-cause death, and serum concentration > 70 mg/dL independently predicted the risk of adverse cardiovascular outcome, but only in patients without diabetes.